Home / Medical Devices / Diabetes Injection Pens Market By Indication (Type I Diabetes, Type Ii Diabetes), By Product Type (Insulin Pens, Insulin Pen Needles), By Form (Disposable, Reusable) - Growth, Future Prospects And Competitive Analysis 2017 – 2025

Diabetes Injection Pens Market By Indication (Type I Diabetes, Type Ii Diabetes), By Product Type (Insulin Pens, Insulin Pen Needles), By Form (Disposable, Reusable) - Growth, Future Prospects And Competitive Analysis 2017 – 2025

Published: May 2017 | Report Code: 58476-05-17

The purpose of this research study titled ‘Diabetes Injection Pens Market - Growth, Future Prospects, and Competitive Analysis, 2017 – 2025’ is to provide investors, developers, company executives and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global diabetes injection pens market. This report presents and analyzes the major trends prevalent in the global diabetes injection pens market and the market size and forecast.

This report categorizes the global diabetes injection pens market in terms of Diabetes type, product type, form and geographical distribution. Based on diabetes type, the global diabetes injection pens market is categorized into type I and type II diabetes. Insulin pens and insulin pen needles are the major product types considered in this study. Furthermore, disposable and reusable forms of diabetes injection pens are also studies in this report. Market size and forecast for each mentioned segment for the period 2015-2025 is presented in the report along with respective CAGRs for the forecast duration 2017-2025.

Geographically, the global diabetes injection pens market is best understood by segmenting the market into five major regions and chief region level markets as follows:

  • North America
    • U.S.
    • Canada
  • Europe
    • EU 7
    • CIS
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Rest of Asia Pacific
  • Latin America Middle East and Africa
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

The market size and forecast of each considered geographical market is presented for the period 2015-2025 along with CAGRs for the forecast period 2017-2025 in this study and are further cross-sectional presented in terms of diabetes type, product type, form, and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global diabetes injection pens market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the diabetes injection pens market. The key players profiled in this report are AstraZeneca plc, Becton, Dickinson and Company, Biocon Ltd., Eli Lilly and Company, Jiangsu Delfu Co., Novo Nordisk A/S, Owen Mumford Ltd. and Wockhardt Ltd.

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Diabetes Injection Pens Market Portraiture
2.1.1. Global Diabetes Injection Pens Market, by Indication, 2016
2.1.2. Global Diabetes Injection Pens Market, by Product Type, 2016
2.1.3. Global Diabetes Injection Pens Market, by Form, 2016
2.1.4. Global Diabetes Injection Pens Market, by Geography, 2016

Chapter 3. Diabetes Injection Pens: Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.4.1. Attractive Investment Proposition, by Geography
3.5. Competitive Landscape
3.5.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Diabetes Injection Pens Market, by Indication, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Type I Diabetes
4.3. Type II Diabetes

Chapter 5. Global Diabetes Injection Pens Market, by Product Type, 2015 – 2025 (US$ Mn)
5.1. Overview
5.2.
5.3. Insulin Pens
5.4. Insulin Pen Needles

Chapter 6. Global Diabetes Injection Pens Market, by Form, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. Disposable
6.3. Reusable

Chapter 7. Global Diabetes Injection Pens Market, by Geography, 2015 – 2025
7.1. Overview
7.2. North America Diabetes Injection Pens Market Analysis, 2015 – 2025
7.2.1. North America Diabetes Injection Pens Market, by Indication, 2015 – 2025 (US$ Mn)
7.2.2. North America Diabetes Injection Pens Market, by Product Type, 2015 – 2025 (US$ Mn)
7.2.3. North America Diabetes Injection Pens Market, by Form, 2015 – 2025 (US$ Mn)
7.2.4. North America Diabetes Injection Pens Market, by Country, 2015 – 2025 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe Diabetes Injection Pens Market Analysis, 2015 – 2025
7.3.1. Europe Diabetes Injection Pens Market, by Indication, 2015 – 2025 (US$ Mn)
7.3.2. Europe Diabetes Injection Pens Market, by Product Type, 2015 – 2025 (US$ Mn)
7.3.3. Europe Diabetes Injection Pens Market, by Form, 2015 – 2025 (US$ Mn)
7.3.4. Europe Diabetes Injection Pens Market, by Region, 2015 – 2025 (US$ Mn)
7.3.4.1. E.U.7
7.3.4.2. CIS
7.3.4.3. Rest of Europe
7.4. Asia Pacific Diabetes Injection Pens Market Analysis , 2015 – 2025
7.4.1. Asia Pacific Diabetes Injection Pens Market, by Indication, 2015 – 2025 (US$ Mn)
7.4.2. Asia Pacific Diabetes Injection Pens Market, by Product Type, 2015 – 2025 (US$ Mn)
7.4.3. Asia Pacific Diabetes Injection Pens Market, by Form, 2015 – 2025 (US$ Mn)
7.4.4. Asia Pacific Diabetes Injection Pens Market, by Country, 2015 – 2025 (US$ Mn)
7.4.4.1. China
7.4.4.2. India
7.4.4.3. Rest of APAC
7.5. Latin America Diabetes Injection Pens Market Analysis , 2015 – 2025
7.5.1. Latin America Diabetes Injection Pens Market, by Indication, 2015 – 2025 (US$ Mn)
7.5.2. Latin America Diabetes Injection Pens Market, by Product Type, 2015 – 2025 (US$ Mn)
7.5.3. Latin America Diabetes Injection Pens Market, by Form, 2015 – 2025 (US$ Mn)
7.5.4. Latin America Diabetes Injection Pens Market, by Country, 2015 – 2025 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa (MEA) Diabetes Injection Pens Market Analysis, 2015 – 2025
7.6.1. MEA Diabetes Injection Pens Market, by Indication, 2015 – 2025 (US$ Mn)
7.6.2. MEA Diabetes Injection Pens Market, by Product Type, 2015 – 2025 (US$ Mn)
7.6.3. MEA Diabetes Injection Pens Market, by Form, 2015 – 2025 (US$ Mn)
7.6.4. MEA Diabetes Injection Pens Market, by Region, 2015 – 2025 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA

Chapter 8. Company Profiles
8.1. AstraZeneca plc
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Becton, Dickinson and Company
8.3. Biocon Ltd.
8.4. Eli Lilly and Company
8.5. Jiangsu Delfu Co.
8.6. Novo Nordisk A/S
8.7. Owen Mumford Ltd.
8.8. Wockhardt Ltd.
8.9. Other Notable Players

List Of Table : 

TABLE 1 Global Diabetes Injection Pens Market, by Indication, 2015 – 2025 (US$ Mn)
TABLE 2 Global Diabetes Injection Pens Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 3 Global Diabetes Injection Pens Market, by Form, 2015 – 2025 (US$ Mn)
TABLE 4 North America Diabetes Injection Pens Market, by Indication, 2015 – 2025 (US$ Mn)
TABLE 5 North America Diabetes Injection Pens Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 6 North America Diabetes Injection Pens Market, by Form, 2015 – 2025 (US$ Mn)
TABLE 7 North America Diabetes Injection Pens Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 8 Europe Bovine Diabetes Injection Pens Market, by Indication, 2015 – 2025 (US$ Mn)
TABLE 9 Europe Diabetes Injection Pens Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 10 Europe Diabetes Injection Pens Market, by Form, 2015 – 2025 (US$ Mn)
TABLE 11 Europe Diabetes Injection Pens Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 12 Asia Pacific Diabetes Injection Pens Market, by Indication, 2015 – 2025 (US$ Mn)
TABLE 13 Asia Pacific Diabetes Injection Pens Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 14 Asia Pacific Diabetes Injection Pens Market, by Form, 2015 – 2025 (US$ Mn)
TABLE 15 Asia Pacific Diabetes Injection Pens Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 16 Latin America Diabetes Injection Pens Market, by Indication, 2015 – 2025 (US$ Mn)
TABLE 17 Latin America Diabetes Injection Pens Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 18 Latin America Diabetes Injection Pens Market, by Form, 2015 – 2025 (US$ Mn)
TABLE 19 Latin America Diabetes Injection Pens Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 20 Middle East and Africa Diabetes Injection Pens Market, by Indication, 2015 – 2025 (US$ Mn)
TABLE 21 Middle East and Africa Diabetes Injection Pens Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 22 Middle East and Africa Diabetes Injection Pens Market, by Form, 2015 – 2025 (US$ Mn)
TABLE 23 Middle East and Africa Diabetes Injection Pens Market, by Country, 2015 – 2025 (US$ Mn)

List Of Figures :

FIG. 1 Diabetes Injection Pens: Market Segmentation
FIG. 2 Global Diabetes Injection Pens Market, by Indication, 2016 (US$ Mn)
FIG. 3 Global Diabetes Injection Pens Market, by Product Type, 2016 (US$ Mn)
FIG. 4 Global Diabetes Injection Pens Market, by Form, 2016 (US$ Mn)
FIG. 5 Global Diabetes Injection Pens Market, by Geography, 2016 (Value %)
FIG. 6 Attractive Investment Proposition, by Geography
FIG. 7 Market Competition Landscape, by Key Players, 2016
FIG. 8 Global Diabetes Injection Pens for Type I Diabetes Market, 2015 – 2025 (US$ Mn)
FIG. 9 Global Diabetes Injection Pens For Type II Diabetes Market, 2015 – 2025 (US$ Mn)
FIG. 10 Global Insulin Pens Market, 2015 – 2025 (US$ Mn)
FIG. 11 Global Insulin Pen Needles Market, 2015 – 2025 (US$ Mn)
FIG. 12 Global Disposable Diabetes Injection Pens Market, 2015 – 2025 (US$ Mn)
FIG. 13 Global Reusable Diabetes Injection Pens Market 2015 – 2025 (US$ Mn)

The global diabetes injection pens market is studied for the following segmentations:

  • Indication
    • Type I Diabetes
    • Type II Diabetes
  • Product Type
    • Insulin Pens
    • Insulin Pen Needles
  • Form          
    • Disposable
    • Reusable

Diabetes Injection Pens Market

Injection pens are observed to be administered in both type I and type II patients. Between these patient groups, type II diabetes acquires the larger revenue share due to large patient population belonging to this condition. In addition, since type II diabetes majorly occurs in adult individuals, rational insulin administration through injection pens is highly prevalent. However, increasing patient base of children suffering with type II diabetes presents lucrative penetration opportunity to the diabetes injection pens manufacturers. Based on injection forms, this market is categorized into disposable and reusable injection pens. Both disposable and reusable forms of diabetes injection pens are nearly equally used across the patients worldwide. However, it is observed that reusable pens are more preferred in the developed markets. It is anticipated that the same trend will continue through the forecast period, with higher preference for disposable injection forms being more preferred in developing economies.

Geographically, the global diabetes injection pens market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Diabetes Injection Pens Market

Among the considered regional markets, North America and Europe together occupy the largest revenue share of the global diabetes injection pens market. In North America and globally, the United States captures the largest revenue share. The dominance of United States is attributed to large diabetic population, better reimbursement system and healthcare awareness about treatment and management of diabetes. The Europe market, however, is observed to be saturated and will undergo average growth rate. Furthermore, Asia Pacific is anticipated to be the fastest progressing regional market for diabetes injection pens. Growing awareness and increased ability of patients to pay for advanced medicine are the key driving factors for Asia Pacific diabetes injection pens market.

The detailed regional classification of the global diabetes injection pens market is as follows:

  • North America (U.S. & Canada)
  • Europe (EU 7, CIS, and Rest of Europe)
  • Asia Pacific (China, India, and Rest of Asia Pacific)
  • Middle East and Africa (GCC and Rest of Middle East and Africa)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients